ClarIDHy: A phase 3 multicenter randomized double-blind study of AG-120 versus placebo in patients with non-resectable or metastatic cholangiocarcinoma with an IDH1 mutation Meeting Abstract
| Authors: | Abou-Alfa, G. K.; Valle, J. W.; Kelley, R. K.; Goyal, L.; Shroff, R. T.; Javle, M. M.; Borad, M. J.; Cleary, J. M.; El-Khoueiry, A. B.; Bendell, J. C.; Macarulla, T. M.; Vogel, A.; Korth, C.; Jiang, L.; Gliser, C.; Wu, B.; Agresta, S. V.; Pandya, S. S.; Zhu, A. X. |
| Abstract Title: | ClarIDHy: A phase 3 multicenter randomized double-blind study of AG-120 versus placebo in patients with non-resectable or metastatic cholangiocarcinoma with an IDH1 mutation |
| Meeting Title: | 2018 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2018 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000436174100525 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2018.36.4_suppl.TPS545 |
| Notes: | Meeting Abstract: TPS545 -- Source: Wos |
